Diabetes Preceptorship Programme 26 and 27 April 2018

 | Post date: 2018/04/28 | 
Diabetes Preceptorship Programme
The Conference entitled  “Diabetes Preceptorship Programme” was held on 26 and 27 April  2018 at institute of endocrinology and metabolism.
Agenda:
Introduction: CVD risk burden in Iran,  Dr Sepanlou
Cariovascular outcome based approach to diabetes management,        Dr Esteghamati
Unmet needs in T2DM management: role of GLP-1RAs,            Prof. Jodar
Coronary microvascular discase,            Dr Khamseh
Diabetes and heart failure: cardiologist perspective,      Dr Sharif kashani
Case record study and discussion,         Moderator: Dr Jodar
Retinal microvascular disease,   Dr Ghasemi
New markers of diabetic nephropathy,  Dr Savaj
Incretin based therapies: are all born equal?,    Prof. Jodar
GLP1RAs/Basal Insulin & combination therapy,             Dr Malek
Interview with patient/s on GLP-1RA,   Moderator: Dr.Khamseh
Real world data on novel diabetes treatment,   Dr Hoseinpanah
Case-record study and discussion,        Moderator: Dr Jodar
Case-record study and discussion,        Moderator: Prof. Jodar

View: 75 Time(s)   |   Print: 3 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

Diabetes perspectives summit 13 October 2017

 | Post date: 2017/10/7 | 
Diabetes perspectives summit 13 October 2017
The Conference entitled  “Diabetes perspectives summit” was held on 13 October 2017 at Evin hotel.
Agenda:
Beyond glycemic control: Hypertension in type 2 diabetes, Dr Hadaegh, Professor of endocrinology and metabolism and Head of Prevention of Metabolic Disorders Research Center at Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Type 2 diabetes: The importance of early treatment, Prof. Angelo Avogaro, Professor of Endocrinology and Metabolism at the School of Medicine of the University of Padova.
After metformin: How to get oriented, Prof. Giaccari, PhD at the University of Rome.
GLP-1 RA therapy in management of type 2 diabetes: Choosing the right agent for individualized care, Prof. Jodar, Professor (Lecturer) of Endocrinology at the Medicine School of the European University of Madrid.
Insulin delivery systems, Prof. Ziegler, Chair of the Board of the German Working Group for Pediatric Diabetes (AGPD).
Addressing dyslipidemia: PCK9 inhibitors and diabetes, Dr Khamseh, clinical endocrinologist, Professor of endocrinology and metabolism and director of
Institute of Endocrinology and Metabolism at Iran University of Medical Sciences, Tehran, Iran
New paradigm for management of type two diabetes, Prof. Giaccari
New Insulin Generations, Prof. Tofe, Senior Consultant in Endocrinology Clinical Trials Coordinator. Servicio de Endocrinología y Nutrición. Hospital Universitario Son Espases Palma de Mallorca.
The present and the future of diabetes: opportunities and challenges worldwide, Prof. Angelo Avogaro

View: 691 Time(s)   |   Print: 40 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

Pituitary monthly seminar 25/sep/2017

 | Post date: 2017/09/26 | 

Pituitary monthly seminar 25/sep/2017:

A case of resistant acromegaly who underwent   surgery (two times) and radiotherapy. He became candidate for a trial of medical therapy.

View: 679 Time(s)   |   Print: 48 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

Pituitary tumor seminar 28/Aug/2017

 | Post date: 2017/09/10 | 
Pituitary tumor seminar 28/Aug/2017:
The meeting  was held by The scientific team(Endocrinologist, Neurologists, Pathologists, Radiologists, Molecular science specialist) .A 23-year-old woman with the Pituitary adenoma(24*17 cm) and Prolactin 177 mg/ml was presented.

View: 675 Time(s)   |   Print: 42 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

Thyroid monthly seminar

 | Post date: 2017/09/10 | 
Thyroid monthly seminar 3/sep/2017:
The meeting  was held by the scientific team( Endocrinologist, General Surgeons, Pathologist, Sonologist, Molecular medicine, and Nuclear imaging). A63-year-old woman with incidentally discovered PTC after subtotal thyroidectomy due to toxic MNG was presented. 

View: 724 Time(s)   |   Print: 50 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)